Newborn Screening for Cystic Fibrosis: Infant and Laboratory Factors Affecting Successful Sweat Test Completion

Area of Science:

• Pediatrics
• Medical Diagnostics
• Genetics

Background:

• Newborn screening (NBS) for Cystic Fibrosis (CF) aims for early diagnosis and treatment.
• Abnormal NBS results necessitate sweat chloride testing (ST) for confirmation.
• Insufficient sweat volume (QNS) during ST can delay diagnosis, with rates often exceeding the <10% benchmark.

Purpose of the Study:

• To identify infant and laboratory factors influencing sweat chloride testing (ST) success rates.
• To assess quality improvement (QI) measures for reducing "quantity not sufficient" (QNS) results in infant ST.
• To optimize the diagnostic pathway for Cystic Fibrosis in newborns.

Main Methods:

• A quality improvement study analyzing infant factors (birth weight, gestational age, ethnicity, sex) and laboratory procedures.
• Evaluation of ST success and QNS rates from 2017-2019.
• Analysis of the impact of targeted interventions like staff education and direct observation.

Main Results:

• Infant birth weight and gestational age significantly impacted the day of life for successful ST completion.
• Implementing enhanced ST education, reducing laboratory technician numbers, and employing direct observation improved ST success rates.
• These QI interventions were effective in reducing QNS rates.

Conclusions:

• Infant characteristics and laboratory practices are critical determinants of ST success in CF NBS.
• Targeted QI initiatives and interdepartmental collaboration can effectively reduce QNS rates.
• Sustained improvements in ST procedures ensure timely diagnosis and treatment for infants with CF.